Anna McGregor
MD Student
Boston University School of Medicine




Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Isenberg D, Furie R, Jones NS, Guibord P, Galanter J, Lee C, McGregor A, Toth B, Rae J, Hwang O, Desai R, Lokku A, Ramamoorthi N, Hackney JA, Miranda P, de Souza VA, Jaller-Raad JJ, Maura Fernandes A, Garcia Salinas R, Chinn LW, Townsend MJ, Morimoto AM, Tuckwell K. Efficacy, Safety, and Pharmacodynamic Effects of the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib (GDC-0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol. 2021 10; 73(10):1835-1846. PMID: 34042314; DOI: 10.1002/art.41811;
     
  2. Braithwaite IE, Cai F, Tom JA, Galanter JM, Owen RP, Zhu R, Williams M, McGregor AG, Eliahu A, Durk MR, Dengler HS, Zak M, Kenny JR, Wilson ME, Beasley R, Chen H. Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trial. J Allergy Clin Immunol. 2021 09; 148(3):783-789. PMID: 33744327; DOI: 10.1016/j.jaci.2021.02.042;
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 2 publications over 1 distinct years, with a maximum of 2 publications in 2021

YearPublications
20212

Contact for Mentoring:

McGregor's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Similar People
_